$UCLE US Nuclear Corp. Overhoff Technology Division

New Post Public Reply Private Reply Replies (0) Message Board
louied91
125
$UCLE US Nuclear Corp. Overhoff Technology Division Forecasts a 50% Increase in 2025 Revenues


https://www.newmediawire.com/news/us-nuclear-...es-7079054

LOS ANGELES, CA - January 23, 2025 (NEWMEDIAWIRE) - US Nuclear Corp. (OTC: UCLE), is pleased to announce that their Overhoff Technology Corp is seeing a surge in orders from the resurgence of interest in nuclear power plants, as well as the military, and pharmaceutical and research labs. The Company is expecting sales growth of 50% in 2025, and possibly a similar increase in 2026 as well.

“Overhoff has been making tritium monitors since 1972, and our products are proven to be the most reliable, and best performing tritium monitors on the market,” said Nikki Truax, Operations Manager for Overhoff.

“Tritium is the main fuel used in fusion power reactors, and as countries around the world make strides in the technology for fusion power generation, there will be a major increase in the demand for Overhoff tritium monitoring instrumentation,” said Nikki Truax. “US Nuclear radiation monitors have direct roots which stretch back to the Manhattan Project, when the founder designed the first radiation monitor, and Overhoff follows in their long tradition of being best-in-class for monitoring instrumentation in the nuclear space.”

“US Nuclear and Overhoff monitors can measure the levels of radiation and tritium in the nuclear space, the levels of carbon-dioxide and methane in the oil and gas space, and the levels of PFAS Forever chemicals, which will take decades to eliminate, in the industrial space,” said Mrs. Truax. “Overhoff and US Nuclear are looking for new Distributors and Sales Reps, to help us service this increasing level of interest in our products”

US Nuclear Corp (UCLE) Stock Research Links

UCLE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Cultural Excellence: Fukuoka Prize 2025 Laureates Revealed

Updated Category News Views 360

Fukuoka City Announces 2025 Fukuoka Prize Winners Fukuoka City has revealed the recipients of the prestigious Fukuoka Prize for 2025, honoring remarkable individuals in the field of Asian studies and the arts. This award is presented to those who excel in preserving and enhancing the rich tapestry of Asian culture. Fukuoka City is dedicated to celebrating these...

Continue Reading
Investors Unite: Join Flywire Corporation Legal Action Today

Updated Category News Views 168

Flywire Corporation Investors Take Action Against Securities Fraud In a moment of reckoning, investors in Flywire Corporation are seizing the opportunity to join a class action lawsuit concerning alleged securities fraud. The filing of this lawsuit has been initiated to hold accountable those responsible for misleading investors during a specified period, marking a...

Continue Reading
Venus Concept Secures $2.7 Million for Growth and Innovation

Updated Category News Views 323

Venus Concept Raises Significant Funds for Future Endeavors Venus Concept Inc. (NASDAQ: VERO), a renowned name in the global medical aesthetic technology arena, recently achieved a noteworthy milestone by closing a registered direct offering that provided around $1.57 million in gross proceeds. The offering consisted of 386,700 shares of common stock, sold at $4.06 each,...

Continue Reading
Revolutionary RAGE: UPENDS Launches Game-Changing Vape System

Updated Category News Views 211

UPENDS Unveils Groundbreaking Open Pod Vape System In a remarkable stride forward for the vaping industry, UPENDS has launched their revolutionary RAGE open pod system, designed to transform how enthusiasts experience vaping. As the European market continues to evolve, this cutting-edge device positions itself as a leader in user-centric innovation and compliance. The...

Continue Reading
Investors Target Kyverna Therapeutics: Key Details You Need

Updated Category News Views 101

Understanding Ongoing Investigations at Kyverna Therapeutics As the financial landscape continues to evolve, investors find themselves keenly interested in the developments surrounding Kyverna Therapeutics, Inc. (NASDAQ: KYTX). With a prominent law firm engaged in scrutinizing potential claims, the situation promises vital updates for concerned stakeholders. Faruqi &...

Continue Reading